.Merck defeats incomes desires, raises sales outlook on strong need for leading medications like Keytruda CNBCMerck & Co. (MRK United States) Defeats Revenue Estimates as Keytruda Sales Surge BloombergMerck Sell: Pharma Titan Posts Sturdy Outcomes, However Overview Tumbles Short Capitalist's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats revenue and also purchases assumptions in the middle of Keytruda strength, yet delivers blended full-year expectation MarketWatch.